fluorodeoxyglucose f18 has been researched along with gdc-0973 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoura, Z; Aumaitre, O; Benameur, N; Cluzel, P; Cohen Aubart, F; Emile, JF; Galanaud, D; Haroche, J; Maksud, P | 1 |
| Aladjidi, N; Amoura, Z; Boussouar, S; Charlotte, F; Cohen Aubart, F; Donadieu, J; Emile, JF; Grenier, P; Haroche, J; Maksud, P; Moyon, Q; Prévot, G | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and gdc-0973
| Article | Year |
|---|---|
Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.
Topics: Adult; Aged; Azetidines; Erdheim-Chester Disease; Fluorodeoxyglucose F18; Humans; Male; MAP Kinase Signaling System; Middle Aged; Piperidines; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Treatment Outcome | 2018 |
Lung Involvement in Destombes-Rosai-Dorfman Disease: Clinical and Radiological Features and Response to the MEK Inhibitor Cobimetinib.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azetidines; Bronchoalveolar Lavage Fluid; Cough; Dyspnea; Female; Fluorodeoxyglucose F18; France; Histiocytosis, Sinus; Humans; Immunosuppressive Agents; Lung; Lung Diseases; Lymphocytosis; Male; Middle Aged; Piperidines; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Registries; Retrospective Studies; Young Adult | 2020 |